6185
COM:CANSINOTECH
康希诺生物
- Stock
Last Close
29.15
22/11 08:08
Market Cap
6.49B
Beta: -
Volume Today
1.73M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|
average inventory | 812K - | 5.06M 523.03% | 12.42M 145.42% | 93.42M 652.46% | 523.07M 459.88% | 776.70M 48.49% | 515.31M 33.65% | ||
average payables | 1.31M - | 4.26M 226.44% | 6.41M 50.32% | 33.37M 420.54% | 451.57M 1,253.14% | 547.84M 21.32% | 178.55M 67.41% | ||
average receivables | -133.39M - | -201.16M 50.81% | -58.82M 70.76% | 8.95M 115.21% | 746.19M - | ||||
book value per share | 0.98 - | 2.78 183.17% | 2.30 17.29% | 7.23 213.96% | 26.29 263.74% | 32.31 22.90% | 27.32 15.45% | 21.38 21.74% | |
capex per share | -0.58 - | -0.85 47.44% | -0.74 13.57% | -0.57 21.94% | -1.17 104.00% | -4.86 314.64% | -4.35 10.49% | -2.47 43.14% | |
capex to depreciation | -19.69 - | -21.90 11.19% | -13.37 38.95% | -5.20 61.07% | -8.51 63.54% | -13.59 59.67% | -5.47 59.71% | -2.32 57.64% | |
capex to operating cash flow | 3.67 - | 3.30 9.96% | 1.30 60.64% | 0.69 47.12% | 0.58 16.05% | -0.60 203.53% | 0.57 195.36% | 0.67 18.02% | |
capex to revenue | -141.94 - | -51.22 63.92% | -14.60 71.49% | -0.28 98.08% | -1.04 272.62% | -1.71 63.97% | |||
cash per share | 0.67 - | 1.93 187.20% | 0.90 53.10% | 3.71 310.11% | 22.15 496.92% | 31.45 42.03% | 24.07 23.46% | 16.74 30.47% | |
days of inventory on hand | 8.70 - | 27.28 213.41% | 40.44K 148,136.48% | 4.51K 88.85% | 246.51 94.53% | 203.17 17.58% | 160.82 20.84% | ||
days payables outstanding | 5.19 - | 10.07 94.22% | 21.36 112.11% | 15.27K 71,405.11% | 1.60K 89.51% | 237.21 85.19% | 75.87 68.01% | 47.39 37.55% | |
days sales outstanding | -43.71K - | 2.86K 106.55% | 651.00 - | ||||||
debt to assets | 0.21 - | 0.13 41.08% | 0.19 50.73% | 0.09 50.48% | 0.02 77.40% | 0.12 448.14% | 0.24 103.38% | 0.28 20.10% | |
debt to equity | 0.32 - | 0.18 44.73% | 0.30 67.41% | 0.11 62.08% | 0.02 79.30% | 0.17 632.40% | 0.40 132.73% | 0.50 24.85% | |
dividend yield | 0.00 - | 0.00 1,388.32% | 0.00 56.00% | 0.00 28.71% | 0.01 - | 0.01 10.69% | |||
earnings yield | -0.01 - | -0.01 39.71% | -0.02 104.17% | -0.01 31.76% | -0.01 26.75% | 0.05 601.74% | -0.07 224.71% | -0.29 347.37% | |
enterprise value | 6.80B - | 6.36B 6.36% | 6.69B 5.06% | 10.66B 59.48% | 29.89B 180.33% | 32.31B 8.10% | 14.01B 56.63% | 4.87B 65.27% | |
enterprise value over ebitda | -150.60 - | -93.91 37.65% | -48.17 48.71% | -77.29 60.46% | -74.17 4.03% | 16.34 122.03% | -13.61 183.30% | -3.28 75.89% | |
ev to operating cash flow | -197.66 - | -113.03 42.82% | -54.07 52.16% | -62.65 15.86% | -63.68 1.64% | 16.04 125.19% | -7.42 146.28% | -5.36 27.83% | |
ev to sales | 5.91K - | 4.67K 20.94% | 1.61K 65.48% | 7.51 99.53% | 13.59 80.85% | 13.63 0.27% | |||
free cash flow per share | -0.74 - | -1.11 50.93% | -1.30 17.39% | -1.41 8.31% | -3.21 127.12% | 3.28 202.30% | -11.99 465.75% | -6.16 48.67% | |
free cash flow yield | -0.02 - | -0.04 63.10% | -0.04 11.71% | -0.03 37.76% | -0.02 19.35% | 0.02 203.00% | -0.20 1,003.54% | -0.30 49.22% | |
graham net net | 0.16 - | -0.17 207.37% | -0.89 417.42% | 2.27 356.17% | 19.58 761.58% | 19.78 1.01% | 8.35 57.79% | 3.05 63.46% | |
graham number | 2.25 - | 4.30 91.34% | 5.73 33.21% | 11.06 93.08% | 30.30 173.93% | 74.99 147.47% | 49.00 34.67% | 53.77 9.74% | |
income quality | 0.69 - | 0.87 26.66% | 0.89 2.35% | 1.09 21.42% | 1.15 6.22% | 1.06 8.39% | 1.59 50.92% | 0.61 61.58% | |
intangibles to total assets | 0.06 - | 0.05 22.32% | 0.06 36.87% | 0.03 50.22% | 0.01 66.58% | 0.02 55.88% | 0.02 35.09% | 0.02 31.43% | |
interest coverage | 93.62 - | -33.11 135.37% | |||||||
interest debt per share | 0.32 - | 0.50 56.50% | 0.69 38.47% | 0.82 19.07% | 0.62 24.71% | 5.64 813.46% | 11.10 96.86% | 10.68 3.77% | |
inventory turnover | 41.93 - | 13.38 68.09% | 0.01 99.93% | 0.08 796.94% | 1.48 1,728.95% | 1.80 21.33% | 2.27 26.33% | ||
invested capital | 0.32 - | 0.18 44.73% | 0.30 67.41% | 0.11 62.08% | 0.02 79.30% | 0.17 632.40% | 0.40 132.73% | 0.50 24.85% | |
market cap | 6.78B - | 6.27B 7.46% | 6.59B 5.09% | 10.70B 62.26% | 34.19B 219.64% | 36.39B 6.43% | 14.71B 59.59% | 5.05B 65.65% | |
net current asset value | 35.10M - | 167.89M 378.24% | -72.55M 143.22% | 480.26M 761.94% | 4.74B 887.67% | 5.96B 25.72% | 3.51B 41.20% | 1.15B 67.22% | |
net debt to ebitda | -0.37 - | -1.33 257.47% | -0.67 49.80% | 0.26 138.73% | 10.68 4,033.33% | -2.06 119.33% | 0.67 132.67% | 0.13 81.37% | |
net income per share | -0.23 - | -0.30 29.29% | -0.63 114.56% | -0.75 18.75% | -1.55 106.30% | 7.74 598.34% | -3.91 150.48% | -6.01 53.88% | |
operating cash flow per share | -0.16 - | -0.26 63.75% | -0.57 119.60% | -0.84 47.63% | -2.03 143.00% | 8.14 500.51% | -7.64 193.86% | -3.68 51.82% | |
payables turnover | 70.39 - | 36.24 48.51% | 17.09 52.85% | 0.02 99.86% | 0.23 853.66% | 1.54 575.21% | 4.81 212.63% | 7.70 60.12% | |
receivables turnover | -0.01 - | 0.13 1,627.52% | 0.56 - | ||||||
research and ddevelopement to revenue | 100.39 - | 66.46 33.80% | 23.11 65.23% | 0.20 99.12% | 0.75 269.35% | 1.79 136.70% | |||
return on tangible assets | -0.16 - | -0.08 52.02% | -0.19 137.89% | -0.09 52.27% | -0.05 39.42% | 0.16 405.33% | -0.09 152.49% | -0.16 87.79% | |
revenue per share | 0.01 - | 0.01 116.33% | 0.08 615.54% | 17.38 21,537.32% | 4.17 75.98% | 1.45 65.32% | |||
roe | -0.23 - | -0.11 54.34% | -0.28 159.41% | -0.10 62.18% | -0.06 43.29% | 0.24 505.49% | -0.14 159.71% | -0.28 96.62% | |
roic | -0.18 - | -0.07 59.42% | -0.19 165.27% | -0.12 38.20% | -0.06 46.43% | 0.20 405.97% | -0.12 158.81% | -0.22 90.47% | |
sales general and administrative to revenue | 18.20 - | 27.50 51.06% | 4.47 83.75% | 0.05 98.79% | 0.27 400.24% | 0.80 197.48% | |||
shareholders equity per share | 0.98 - | 2.78 183.17% | 2.30 17.29% | 7.23 213.96% | 26.29 263.74% | 32.31 22.90% | 27.32 15.45% | 21.38 21.74% | |
stock based compensation to revenue | 13.94 - | 9.42 32.40% | 0.94 89.98% | 0.00 99.76% | 0.01 328.98% | 0.03 173.28% | |||
tangible asset value | 194.72M - | 566.57M 190.97% | 451.06M 20.39% | 1.41B 213.33% | 6.00B 324.44% | 8.35B 39.19% | 6.99B 16.32% | 5.14B 26.39% | |
tangible book value per share | 0.89 - | 2.60 190.97% | 2.07 20.39% | 6.95 236.03% | 25.98 273.96% | 33.74 29.89% | 28.28 16.18% | 20.85 26.29% | |
working capital | 119.45M - | 313.99M 162.87% | 114.32M 63.59% | 669.95M 486.04% | 5.01B 647.49% | 6.41B 28.10% | 4.79B 25.36% | 2.62B 45.37% |
All numbers in (except ratios and percentages)